We’re excited to lead a $21M ARPA-H initiative with
@amgen.bsky.social and top academics to build AI models for drug toxicity - improving drug safety. We’re generating human organoid, MPS, and ex vivo tissue data to build digital liver & heart models.
inductive.bio/news/inducti...

Fixing drug discovery’s most persistent problem with AI Discover the role of AI in overcoming the challenges of ADMET in drug discovery, streamlining the development of new therapies.

Can AI fix one of drug discovery’s biggest bottlenecks? At Inductive, we think so - by making ADMET optimization faster and smarter. In this new Drug Target Review, our CEO Josh Haimson shares how: www.drugtargetreview.com/article/1683...

We’re thrilled to announce that our latest generation of Beacon-1 ADMET models secured first place in the recent @polarishub.io ASAP blinded prediction challenge focused on ADMET properties in a real ASAP discovery antiviral program. Read about our lessons learned: www.inductive.bio/blog/lessons...

Inductive Bio Raises $25M Series A Funding will accelerate company’s work to democratize state-of-the-art AI models trained on a pre-competitive dataset to speed the successful development of life-saving therapies

Big news: Inductive has raised a $25M Series A to democratize AI that transforms small molecule drug discovery.

Our Compass platform, powered by our pre-competitive data consortium, predicts ADMET properties before synthesis - helping find higher quality drugs for patients, faster.

#DrugDiscovery

Thank you to our sponsors @inductivebio.bsky.social @emolecules.bsky.social @acsmedi.bsky.social Enamine, Schrödinger, and Merck

LLMs’ impact in generative chemistry has been limited to date. We show that a slight change in how you ask the question, simply by switching the input from SMILES to IUPAC, can reduce invalid molecules by >90%.
Learn more: inductive.bio/blog/molecul...
#GenerativeChemistry #AI #ML

Tired of the local vs. global property-prediction model debate? Why not both? Our blog dives into this debate and provides evidence that a combined global+local approach performs the best. Learn more: inductive.bio/blog/local-v... #DrugDiscovery #ML #ADME #Biotech

Inductive Bio Announces Publication of Successful Drug Optimization Collaboration with Nested Therapeutics Inductive Bio, a leader in leveraging machine learning (ML) to accelerate compound optimization for small molecule drug discovery, announces the publication of the approach and findings from their rec...

Sharing that our exciting work with Nested Therapeutics in drug optimization is published! 🧬Our ML models helped overcome critical ADME issues to advance Nested’s program. Full story: inductive.bio/news/publica... #DrugDiscovery #ML #ADME #Biotech

Our blog on Alpha Fold 3 explores how AF3 small-molecule docking compares to existing techniques and shows that the story is more nuanced than headlines suggest. inductive.bio/blog/strong-...